SCHEMBL856771

SCHEMBL856771

Cc1ccc2ncnc(N3CCOc4ccc(-c5cnc6[nH]c(OC(N)=O)nc6c5Cc5ccccc5)cc4C3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 7/20 0.37
PDGFRB P09619 1/20 0.36
CYP2C19 P33261 5/20 0.35
ALDH1A1 P00352 4/20 0.35
CLK4 Q9HAZ1 4/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
HIF1A Q16665 2/20 0.35
GPR142 Q7Z601 1/20 0.35
KIT P10721 3/20 0.34
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
KMT2A Q03164 1/20 0.34
PIK3CA P42336 1/20 0.34
CYP2D6 P10635 1/20 0.33
AKT1 P31749 1/20 0.33
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856773 0.76 PIK3CA (0.40) CREBBPPDGFRBCYP2C19ALDH1A1CLK4
SCHEMBL856772 0.75 PIK3CA (0.38) CREBBPPDGFRBCYP2C19ALDH1A1CLK4
SCHEMBL3757572 0.74 PIK3CA (0.39) CREBBPPDGFRBCYP2C19ALDH1A1CLK4
SCHEMBL6126132 0.73 PIK3CA (0.40) CREBBPPDGFRBCYP2C19ALDH1A1CLK4
SCHEMBL856147 0.71 CYP3A4 (0.41) CYP2C19ALDH1A1CLK4TSHRMAPK1
SCHEMBL857187 0.70 PIK3CA (0.51) CYP2C19ALDH1A1CLK4TSHRMAPK1
SCHEMBL3763910 0.69 PRMT5 (0.45) CYP2C19ALDH1A1CLK4TSHRMAPK1
SCHEMBL858375 0.69 PIK3CA (0.46) CREBBPALDH1A1TSHRMAPK1MEN1
SCHEMBL3716268 0.69 PIK3CA (0.42) CREBBPCYP2C19ALDH1A1CLK4TSHR
SCHEMBL3807014 0.68 PIK3CA (0.45) ALDH1A1MEN1KMT2APIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed